There is evidence indicating that sperm plays a role in determining blastocyst ploidy status. In our study, we aim to compare the outcomes of preimplantation genetic testing for aneuploidy (PGT-A) and the subsequent clinical outcomes following transfers of euploid embryos. This comparison will be conducted between cases where ejaculated sperm and cases where testicular sperm were used for intracytoplasmic sperm injection (ICSI), specifically focusing on severe male factor infertility patients.
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Euploidy rate
Timeframe: 15 days post ICSI
Aneuploidy rate
Timeframe: 15 days post ICSI
Low mosaic rate
Timeframe: Time Frame: 15 days post ICSI
High mosaic rate
Timeframe: Time Frame: 15 days post ICSI
Implantation rate
Timeframe: 6-9 weeks post-embryo transfer
Ongoing pregnancy rate
Timeframe: 12 weeks of gestation
Miscarriage rate
Timeframe: after 6 weeks of gestation
Clinical pregnancy rate
Timeframe: 6-9 weeks post-embryo transfer